Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Modification of drug biotransformation by vitamin C in man

Abstract

VITAMIN C (ascorbic acid) is taken by many individuals in very large doses and there has been some concern about possible adverse effects of such regimens. It has been found that vitamin C is metabolised in part to ascorbic acid sulphate in man1. Sulphate formation is also an important pathway for the biotransformation of phenolic drugs2. This pathway is, however, of limited capacity in man3 (and in many species of animals) and is therefore subject to saturation and competitive inhibition. Such mutual inhibition by two or more substrates is caused by the limited availability of sulphate and can be overcome by concomitant administration of sulphate or a sulphate donor3. Studies in man have demonstrated competitive inhibition of sulphate formation between acetaminophen and salicylamide, two widely used analgesics and antipyretics, and the prevention of this inhibition by concomitant administration of the sulphate donor L-cysteine4. We now report the results of a study which shows that concomitant administration of vitamin C and salicylamide causes a decrease in the conversion of the latter to salicylamide sulphate.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Baker, E. M., Hammer, D. C., March, S. C., Tolbert, B. M., and Canham, J. E., Science, 173, 826–827 (1971).

    Article  ADS  CAS  Google Scholar 

  2. Williams, R. T., Detoxification Mechanisms, second ed., ch. 9, 279–282 (Chapman and Hall, London, 1959).

    Google Scholar 

  3. Levy, G., and Matsuzawa, T., J. Pharmac. exp. Ther., 156, 285–293 (1967).

    CAS  Google Scholar 

  4. Levy, G., and Yamada, H., J. Pharm. Sci., 60, 215–221 (1971).

    Article  CAS  Google Scholar 

  5. Hunt, J. N., and Knox, M. T., J. Physiol., Lond., 222, 187–208 (1972).

    Article  CAS  Google Scholar 

  6. Kubler, W., and Gehler, J., Int. Z. Vitaminforsch., 40, 442–445 (1970).

    CAS  PubMed  Google Scholar 

  7. Physicians Desk Reference, 28th ed., 1574–1578 (Medical Economics, Oradell, New Jersey, 1974).

  8. Levy, G., Ann. N.Y. Acad. Sci., 179, 32–42 (1971).

    Article  ADS  CAS  Google Scholar 

  9. George, C. F., Blackwell, E. W., and Davies, D. S., J. Pharm. Pharmac., 26, 265–267 (1974).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

HOUSTON, J., LEVY, G. Modification of drug biotransformation by vitamin C in man. Nature 255, 78–79 (1975). https://doi.org/10.1038/255078a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/255078a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing